Background: Patients with bicuspid aortic valve (BAV) show altered hemodynamics in the ascending aorta that can be assessed by 4D flow MRI. Purpose: Comprehensive cardiac MRI was applied to test the hypothesis that BAV-mediated changes in aortic hemodynamics (wall shear stress [WSS] and velocity) are associated with parameters of left ventricular (LV) remodeling. Study Type: Retrospective data analysis. Population: Forty-nine BAV patients (mean age 5 50.2 6 13.5, 62% male). Field Strength/Sequence: Balanced steady-state free precession (bSSFP)-CINE, pre-and postcontrast T 1 mapping with modified Look-Locker inversion recovery (MOLLI), time-resolved 3D phase-contrast (PC) MRI with three-directional velocity encoding (4D flow MRI) at 1.5 and 3T. Assessment: Quantification of LV volumetric data and myocardial mass, extracellular volume fraction (ECV), aortic valve stenosis (AS), and regurgitation (AR). 3D aortic segmentation, quantification of peak systolic velocities, and 3D WSS in the ascending aorta (AAo), arch, and descending aorta (DAo). Statistical Tests: Two-sided nonpaired t-test to compare subgroups. Pearson correlation coefficient for correlations between aortic hemodynamics and LV parameters. Mean systolic WSS in the AAo, peak systolic velocities in the AAo and arch, and LV mass were significantly higher (P < 0.001) in the AS/AR group compared to the patients without AS/AR. In the complete group, we observed significant relationships between increased LV mass and elevated peak systolic velocity (r 5 0.57, r 5 0.58; P < 0.001) and WSS in the AAo and arch, respectively (r 5 0.54, r 5 0.46; P < 0.001). We detected an association between ECV and WSS in the AAo (r 5 0.38, P 5 0.02). These relations did not hold true for patients without AV dysfunction. Data Conclusion: AS and AR in BAV patients have a major impact on elevated aortic peak velocities and WSS that were associated with parameters of LV remodeling. Level of Evidence: 3 Technical Efficacy: Stage 3
years, need regular imaging follow-up for standardized assessment of the AAo diameter to prevent risk of complications with aortic growth and for prophylactic surgical or interventional planning. 3, 4 Common valvular complications associated with BAV with increasing age are aortic valve stenosis (AS) or aortic regurgitation (AR), which affect both aortic hemodynamics and cardiac function by increased loading of the left ventricle (LV). 1 Previous cardiovascular magnetic resonance (MR) studies have shown that BAV morphology is associated with altered aortic hemodynamics in terms of altered 3D blood flow patterns, increased peak velocities, and eccentrically elevated wall shear stress (WSS) in the AAo. 5, 6 Even patients with normally functioning BAV (ie, no AS/AR) frequently develop changes in aortic hemodynamics. 5, 7 Specifically, studies have shown that elevated peak velocities and systolic WSS are associated with development of BAV aortopathy 8 and aortic wall degeneration. 9 However, the impact of these aortic changes on LV loading and subsequent risk for LV remodeling and thus impaired cardiac function is poorly understood. Recent advances in MR allow for the simultaneous assessment of cardiac structure and function by CINEimaging and T 1 -mapping. In addition, 4D flow MRI enables a comprehensive assessment of vascular hemodynamics, including the quantification of 3D WSS along the vessel lumen for the detection of pathological WSS. 7, 10 A first effort was recently made to investigate relationships between blood flow patterns in the AAo and LV remodeling in patients with AS. 11 This study, however, did not use preand postcontrast T 1 -mapping techniques for calculation of the gadolinium extracellular volume fraction (ECV), which can help to identify diffuse structural myocardial changes such as interstitial fibrosis.
12,13
The aim of this pilot feasibility study was therefore to use both 4D flow MRI, pre-and postcontrast T 1 -mapping, in addition to standard-of-care cardiovascular assessment for the analysis of potential associations between abnormal aortic hemodynamics (WSS and peak systolic velocities) and parameters of LV remodeling (volumes, mass, and ECV). We hypothesized that there is a relationship between alterations in aortic hemodynamics and evidence of LV remodeling in BAV patients.
Materials and Methods

Study Cohort
Fifty-two patients with BAV were retrospectively identified in a chart review from a larger group of BAV patients who underwent 4D flow MRI and T 1 -mapping as part of their cardiovascular MR assessment between January and August 2016. All patients were included in accordance with an Institutional Review Board (IRB) approval and waiver of consent. We initially excluded patients with diagnosed myocarditis or myocardial infarction from the study. Two patients were excluded during the MRI assessment due to associated repaired aortic coarctation. In addition, we excluded one patient after the first assessment because he proved to be an outlier in the group with no AV pathology. Forty-nine BAV patients were included in the final study cohort (age 5 50.2 6 13.5 years, median 54 years, range 22-70 years, 62% male [ Table 1 ]). None of the patients met criteria of hypertrophic cardiomyopathy. Patients with high AAo flow velocities above 6 m/s and occurrence of aliasing were excluded a priori as well. Hematocrit and creatinine was measured before cardiovascular magnetic resonance (CMR), and all the patients had glomerular filtration rate (GFR) >60 using the previously described equation.
14 Patient hematocrit was collected within 48 hours of the cardiac MRI exam.
MRI Protocol
All patients underwent a standard-of-care cardiac MRI exam on a 1.5T (36 patients) or 3T (13 patients) MRI system (Magnetom Heart rate (beats/min) 65 6 9 6 4 6 10 67 6 8
Avanto/Aera, Skyra, Siemens Medical Systems, Erlangen, Germany) including electrocardiogram (ECG)-gated time-resolved (CINE) 2D steady-state free precession (SSFP) MRI in the short axis (full coverage from base to apex) for the evaluation of cardiac dimensions and global function parameters (Fig. 1a) . 2D-CINE phase contrast (PC) sequences were performed at the level of the AV to assess peak flow velocities and to quantify regurgitant fraction. Contrast-enhanced MR angiography was acquired after intravenous contrast agent administration (bolus infusion, dose 5 0.2 mmol/ kg, gadobutrol, Gadavist, Bayer Pharmaceuticals, Whippany, NJ). T 1 -mapping was performed using a modified Look-Locker inversion recovery (MOLLI) technique, utilizing a 5(3)3, two T 1 experiments pre-and 4(1)3(1)2 postcontrast technique. 15 Data for each slice (base, mid, apex) were acquired during breath-holding pre-and 10-25 minutes following intravenous contrast agent administration. Imaging reconstruction included inline motion correction of the MOLLI images with different inversion times, and the calculation of parametric LV T 1 maps (see Fig. 1b,c) For the assessment of aortic hemodynamics, time-resolved 3D phase-contrast (PC) MRI with three-directional velocity encoding (4D flow MRI) was performed to measure 3D blood flow velocities with full volumetric coverage of the thoracic aorta. 4D flow MRI was performed 25-35 minutes postcontrast at the end of the MR study after T 1 -mapping and delayed enhancement imaging. 4D flow MRI was acquired during free breathing using respiratory and prospective ECG gating with a target efficiency of 80%, as described previously leading to a scan time of 8-12 minutes. 17 Pulse sequence parameters were as follows: spatial reso- 
Data Analysis: LV Function and Structure
Left ventricular end-diastolic and end-systolic volumes (LVEDV and LVESV), stroke volumes (SV), and ventricular mass were assessed for each patient using Syngo Argus (Siemens Medical Solutions) and normalized to the patient's body surface area (BSA). The papillary muscles were not included in the myocardial mass calculation. Ejection fraction (EF) was automatically calculated. Epi-and endocardial LV contours (base, mid, apex) were manually delineated in the pre-and postcontrast T 1 -maps using Circle (CMR42, Circle Cardiovascular Imaging, Calgary, Canada). Myocardial ECV was automatically calculated using the formula ECV5
T1post2T1 pre blood T1post2T1 pre myocardium 3ð12hematocritÞ. 18 Basal, mid, and apical locations were averaged to obtain the global LV ECV.
Data Analysis: Aortic Valve Morphology
SSFP-CINE-images were evaluated by cardiovascular radiologists (J.D.C., J.C.C.) with 15 and 20 years of experience, respectively, with regard to AV morphology and Sievers type. 19 Peak flow velocities and flow volumes for AS and AR assessment, and aortic valve orifice area were quantified by manual segmentation in 2D-CINE-PC images (Syngo Argus, Siemens Medical Solutions). AS and AR severity were graded on a 3-point scale (mild, moderate, severe) based of the orifice area and peak velocity or retrograde flow volume, respectively, according to international guidelines. 20 Since it was not the aim of this study to investigate correlations between the degree of AV pathology and aortic hemodynamics, we defined all subgroups in general, either with stenosis or with regurgitation, as pathology, ie, as additional AV dysfunction.
Data Analysis: AAo Diameter, Aortic Peak Systolic Velocities and 3D WSS
Cross-sectional aortic diameter was assessed on multiplanar reformatted MR-angiogram (MRA) images in the mid AAo at the level of the midpoint between sinotubular junction and origin of the brachiocephalic trunk in accordance with international guidelines. 21 The diameters were calculated from an average of two orthogonal measurements. The presence of AAo dilatation was defined as a diameter of the AAo >4.0 cm.
21
4D flow data preprocessing included noise filtering and correction for eddy currents, Maxwell terms, and velocity aliasing, as described previously.
22 3D PC-MRA images, weighted for systolic timeframes, were derived from 4D flow data by multiplication of the PC magnitude images with the absolute velocity images. The 3D PC-MRA images were subsequently used to semiautomatically segment the thoracic aorta using a commercial software package as illustrated in Fig. 1d (MIMICS, Materialise, Leuven, Belgium). The aorta segmentation was used to mask the 4D flow velocity data and to calculate a maximum intensity projection (MIP) of the peak systolic absolute velocities in sagittal orientation as shown in Fig. 1e . This method has recently been introduced and has been proven valuable for fast and improved detection of regional peak systolic velocities frequently found in BAV patients. 23 Regions of interest in the peak velocity MIP covering the AAo, arch, and DAo were used to automatically extract maximum velocities in all three aortic segments. 23 In addition, peak systolic 3D WSS was calculated along the entire aortic wall using the same approach as described previously (see Fig. 1f ). 10, 24 Regional mean peak systolic WSS values were obtained by segmentation of the thoracic aorta in three defined segments for the AAo, arch, and DAo, analogous to the regional MIP assessment.
Statistical Analysis
The assumption of normal distribution was assessed for each parameter using the Kolmogorov-Smirnov test. Quantitative values between different subgroups of the BAV cohort were compared using a two-sided nonpaired t-test. Continuous data were expressed as mean 6 SD. Correlations between aortic hemodynamics parameters (peak systolic velocity and WSS in the AAo and arch) and LV parameters were assessed using the Pearson correlation coefficient. Statistical significance was indicated by P < 0.05. Statistical analysis was performed using statistical software SPSS (IBM, Armonk, NY).
Results
Aortic Valve
According to the Sievers classification, 19 40 patients had a type I -RL BAV, 6 type I -RN, 2 type 0, and one type 2. The mean aortic valve area was 3.5 6 1.8 cm 2
. After dividing the complete BAV cohort into patients with and without additional AV dysfunction, 35/49 patients had AV dysfunction in terms of AS (seven patients), AR (n 5 16), or both AS and AR (n 5 12). Complete details regarding the study cohort, AV morphology and cardiac function are found in Tables 1 and 2 .
Cardiac Assessment
As shown in Tables 2 and 3 , cardiac analysis resulted in normal systolic cardiac function, expressed by a mean EF of 62 6 6% (median 62%, 43-71%). Only three patients had an EF below 55%. LV dimensions (indexed EDV and ESV values) were within normal ranges, mean myocardial mass index of the complete cohort was 74 . Mean ECV was not elevated (25.9 6 2.8%, median 26.0%, 20.9-34.3%). ECV of the basal cardiac segments was nearly the same (25.5 6 3.1%, median 25.0%, 20.3-34.9%).
We detected significantly increased LV mass (P < 0.001) in the AS/AR group compared to the patients with normal AV function. After further subdividing the AS/AR group into the subgroups AS, AR, and AS1AR, LV mass was larger in the AR (P 5 0.01) and AS1AR group (P < 0.001) but not in the AS group (P 5 0.17) in comparison with the no AS/AR group. Global and basal ECV were not significantly elevated in the subgroup with AV dysfunction compared to the group without AV dysfunction (26.2 6 2.4% vs. 25.2 6 3.7%; 25.8 6 3.0% vs. 24.6 6 3.1%). However, when normalizing ECV to the muscle mass, we obtained significant differences between the patients with and without AV dysfunction (0.35 6 0.09 vs. 0.43 6 0.11, P 5 0.02).
Aortic Dimensions, Velocity, and WSS Results of the assessment of aortic dimension, peak velocity, and WSS are summarized in Table 3 . The mid AAo diameter was enlarged (>4 cm) in 25/49 patients, the mean diameter was 4.0 6 0.8 cm, (median 4.1) with a range between 2.6 cm and 5.4 cm. Mean AAo diameters were similar in BAV patients without AV dysfunction compared to the group with additional AS/AR (3.7 6 0.8 cm vs. 4.2 6 0.7 cm; P 5 0.06), whereas mean aortic arch diameters were significantly smaller (2.7 6 0.3 cm vs. 3.0 6 0.4 cm; P 5 0.01).
We detected significantly increased peak velocities in the AAo (P < 0.001) and arch (P < 0.001), peak systolic WSS in the AAo (P < 0.001) in the group with AV dysfunction compared to the no AS/AR group.
Mean peak systolic velocities in the AAo were 2. Significantly increased peak systolic AAo velocities (AS: P < 0.001; AS1AR: P < 0.001) and AAo WSS (AS: P 5 0.003; AS1AR: P < 0.001) were detected for the AS and AS1AR group and elevated peak systolic velocity in the arch of the AS1AR cohort (P < 0.001).
Examples for comprehensive cardiovascular assessment in patients with and without AV dysfunction are shown in Figs. 2 and 3 . Figure 2 illustrates representative findings in a BAV patient with stenotic type I -RL BAV. Figure 3 depicts a side-by-side comparison of two patients with stenotic type 2 and nonstenotic type 0 BAV to demonstrate the cardiac and aortic results depending on AV dysfunction.
Ventricular-Aortic Associations
Ventricular-aortic analysis in the complete study cohort revealed significant relationships between increased LV mass and elevated peak systolic velocity (r 5 0.57, P < 0.001) and increased WSS in the AAo (r 5 0.54, P < 0.001) (Figs. 4 and 5a) , and between LV mass and elevated peak systolic velocity and WSS in the aortic arch (r 5 0.58, P < 0.001, r 5 0.46, P < 0.001).
In addition, we detected associations between AAo WSS and ventricular volumes (EDV: r 5 0. Patients with AV dysfunction revealed significant associations between LV mass and WSS arch (r 5 0.58, P < 0.001), between LV mass and AAo/arch velocity (r 5 0.46, P 5 0.006; r 5 0.53, P 5 0.002) (Figs. 4 and 5b) . In the subgroup without AS/AR, however, there were no significant relationships between LV mass and hemodynamic parameters in the AAo and arch (Figs. 4 and 5c ).
In addition, there were significant associations between elevated WSS and peak velocities in the arch with increased LVEDV (r 5 0.64, P 5 <0.001; r 5 0.35, P 5 0.04) and with increased LVESV (r 5 0.58, P < 0.001; r 5 0.37, P 5 0.03) in patients with AV dysfunction, which were not present in the no AS/AR group. These relationships between increased WSS in the AAo, WSS, and velocity in the arch and the LV volumetric results were also detected in the AR group (AAo WSS and LVEDV/LVESV: r 5 0.69, P 5 0.004; r 5 0.65, P 5 0.009), (arch WSS and LVEDV/ LVESV: r 5 0.80, P < 0.001; r 5 0.7, P 5 0.004), (arch velocity and LVEDV/LVESV: r 5 0.82, P < 0.001; r 5 0.70, P 5 0.004). Finally, a significant association was found between increased AAo WSS and elevated ECV for the complete cohort (r 5 0.38, P 5 0.01) and the AS/AR group (r 5 0.41, P 5 0.01) but not for BAV patients with normal AV function (r 5 0.34, P > 0.05).
Discussion
The findings of our study demonstrate the potential of the comprehensive application of 4D flow MRI and cardiac MRI including T 1 -mapping techniques for the assessment of altered aortic hemodynamics and LV remodeling in BAV patients. As expected, relationships concerning LV parameters in terms of volumes and ECV and increased peak systolic velocities and WSS in the AAo and arch were strongly influenced by the presence of AV dysfunction.
Previous 4D flow MRI studies in BAV patients have focused on the characterization of altered aortic hemodynamics and have shown different flow patterns, valve opening angles, flow displacement, and WSS distribution in the AAo depending on the BAV type. 5, 7, 8, 25, 26 There is an ongoing debate on the genetic versus hemodynamic origin of the frequently observed progressive AAo dilatation. Currently, it is believed that BAV represents one component of a disease spectrum that includes abnormalities in the aortic wall and appears to have partially similar degenerative changes but less severe clinical consequences than Marfan syndrome. 27, 28 Current work suggests that the pathophysiology in BAV is related to the interaction of abnormal WSS distribution, altered aortic wall structure, and an underlying genetic component. 28, 29 This hypothesis is supported by a recent study in BAV patients: increased WSS corresponded with extracellular matrix protein dysregulation and elastic fiber degeneration in the AAo, implicating valve-related hemodynamics as a mediator of aortopathy.
9
A recent study investigated the impact of AS on aortic blood flow, WSS, and LV remodeling in a cohort of 37 patients; among those were 16 with BAV. 11 In this study, stenotic BAV resulted in higher AAo WSS than stenotic TAV, and AV orifice area and flow displacement were associated with signs of LV remodeling. 11 In the aforementioned study, T 1 -mapping techniques were not carried out to examine structural myocardial effects in addition to volumetric changes as a result of valve disease. Moreover, WSS was not analyzed in its 3D character but was limited to three defined 2D analysis planes placed along the AAo.
Our results revealed significantly elevated AAo WSS in patients with AV dysfunction compared to those with normally functioning BAV. This included patients with isolated AS and those with AS and AR, but not the AR group, indicating that the stenotic component causes these WSS differences in comparison to the BAV patients without additional AS/AR. High flow velocity and eccentric flow have previously been shown to result in progression of aortic diameter and rise in WSS. 5, 6 Therefore, these findings are not surprising and can be explained by the underlying valve disease in addition to the congenital BAV component. We used several currently available sequences for cardiovascular assessment to comprehensively analyze both aortic hemodynamics and LV performance within one examination. CINE-SSFP sequences in the short axis orientation for the assessment of LV volumes and function have been used for more than a decade. 30, 31 MOLLI for T 1 -mapping of the heart is widely applied today, with some protocol optimization and other adaptations. 16, 32 ECV as a marker of interstitial fibrosis is particularly valuable for the characterization of more diffuse diseases that are more challenging to detect using conventional late gadolinium enhancement (LGE). 16, 18, 33, 34 Comparing the BAV patients' LV mass in our study to reference values, 30, 31 patients without AV dysfunction and those with isolated AS were within normal limits, while the other subgroups had a significantly larger LV mass, most likely caused by AR. LV hypertrophy in BAV patients without AS was also described in a study by Grotenhuis et al. 35 Aortic dilation and reduced elasticity were associated with AR and LV hypertrophy. Elevated ECV-only measured in the septal region-was described in adult patients with severe acquired AS. 36 Correlations between diffuse myocardial fibrosis and LV mass were seen in a study in which endomyocardial biopsy was performed in the septum. 37 This study revealed more interstitial fibrosis in patients with AR compared with AS. Similar to the study of Singh et al on asymptomatic AS patients, 38 we did not find differences between the ECV values in patients with AV dysfunction and those with normal AV function. In our patient cohort, we did not detect any associations between ECV and LV mass. ECV correlated moderately with AAo WSS in all patients and those with AS1AR but not in patients with normal valve function. A more distinct LV reaction as a result of the valve-induced afterload is presumably the reason for these findings. We believe that BAV patients may develop more severe LV hypertrophy and signs of mild interstitial fibrosis, and thus more manifest LV remodeling in the presence of concomitant valve dysfunction. In this context, AS/AR had a marked impact on the observed relationships between LV mass with peak systolic velocities and WSS in the AAo. These findings are in line with the expected high-pressure gradients across the dysfunctional aortic valve that are associated with a rise in myocardial mass and higher flow velocities and, thus, higher WSS.
There are several limitations in this work. The BAV patients were examined at 1.5 and 3T scanners. Since the field strength influences T 1 values, we focused on ECV for the assessment of structural myocardial changes. Our BAV patient cohort consisted of a heterogeneous group regarding BAV type (Sievers) and concomitant AV pathology in 70% of the cases. This heterogeneity resulted in rather small subgroups after dividing the complete cohort according to the type of valve dysfunction. In particular, the AS subgroup included only seven patients with various AS severity, is underrepresented, and mainly the cause for the absence of any relationship between AS and LV mass. Besides, it was not the aim of this study to investigate the impact of different BAV fusion patterns.
Hypertension is also known to have an impact on LV remodeling. 39 As the data were assessed retrospectively, we did not have the patients' blood pressure values but retrieved this information from the patients' medical reports. A limitation of our study is related to medical therapy in a subgroup of patients. Twelve of 49 patients (24%) received antihypertensive therapy, which may have impacted cardiac remodeling. Future studies should more systematically investigate the impact of antihypertensive therapy on LV changes and whether different types of drugs (eg, ACE inhibiters vs. diuretics) have divergent effects. The analysis of our study cohort did not permit the assessment of these subgroups with statistical certainty.
Age is another factor affecting aortic hemodynamics. 40 Even though the patients with AV dysfunction were older than those with normal AV function, this difference was only significant for the small group of patients with AS. The age between the complete AS/AR cohort and the no AV-pathology group did not differ significantly.
LV reference values provided in previous studies added the papillary muscles to the myocardial mass, 30 ,31 whereas we did not include the papillary muscles in the LV mass due to technical aspects in the analysis software. In this setting, we only measured global cardiac function; therefore, subclinical systolic dysfunction in terms of abnormal LV shape due to volume overload from AR could be missed. In addition, the lack of a reference group, whether healthy volunteers or, ideally, patients with TAV, limits our study's validity. TAV patients with normal valve function do not generally have an indication for undergoing CMR and those with AV dysfunction would presumably not be a useful comparison group. Furthermore, IRB approval for a study with healthy volunteers receiving contrast medium is challenging in this context. Echocardiography was not performed in all subjects within the same period as the MRI scan in order to use it as a reference imaging modality. In addition, a retrospective study has its inherent biases with regard to the study setup.
In general, despite ongoing technical development, 4D flow MRI is still a rather time-consuming method for acquisition and data postprocessing. The same critique point could be discussed for T 1 -mapping. However, these are advanced techniques that provide essential information on hemodynamics and structural myocardial changes compared to conventional MRI sequences used in the routine clinical setting. This additional knowledge enables an improved understanding of complex cardiovascular relationships like in BAV patients.
In conclusion, AV dysfunction in terms of AS and AR has a major impact on cardiac structure, function, and aortic hemodynamics in BAV patients. In our study, BAV patients with no additional AV pathology did not reveal signs of LV impairment due to altered aortic hemodynamics.
